Home > preclinical model
Published on
Related News
AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Related News
Published on 20/03/2022
Understanding hidradenitis suppurativa
Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa
Published on 20/01/2022
Glue degraders for skin diseases
Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases
Published on 05/07/2021
BIOMAP: Understanding inflammatory skin conditions
Almirall joins BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) as a new partner
